Not sure about Mexico ... May be waiting on data like the rest of us.... Or who knows...... Eventually they will get around to using it as it becomes mainstream if they can even get it. U.S. will take all of the supply unless the FDA tries something stupid .... At that point Mexico would become much more important or any country wanting in post data.... As the supply is limited..... Honestly if results are strong which we expect or an improvement over the current standard of care which is a given .. (Safety alone practically insures this not to mention moa) the FDA would be really ...i mean really dumb to extend are trials and allow supply to be picked up by another country.... May be a little bit of chess going on in regards to talks with other countries imo... As they are not likely to receive product anytime soon if fda approves ... But do provide leverage or options if they mess around ...